Case studies of FDA recently approved product applications using real-world evidence-What are the attributes of studies that support effectiveness determinations?

被引：0
|
作者：
Li, Jie [1 ]
Dal Pan, Gerald J. [2 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] FDA, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
325
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [1] The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications
    Purpura, Christina A.
    Garry, Elizabeth M.
    Honig, Nicholaas
    Case, Abigail
    Rassen, Jeremy A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 135 - 144
  • [2] Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far?
    Mavridis, Theodoros
    Deligianni, Christina, I
    Karagiorgis, Georgios
    Daponte, Ariadne
    Breza, Marianthi
    Mitsikostas, Dimos D.
    PHARMACEUTICALS, 2021, 14 (07)
  • [3] Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
    Mahendraratnam, Nirosha
    Mercon, Kerra
    Gill, Mira
    Benzing, Laura
    McClellan, Mark B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 150 - 154
  • [4] USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS
    Lu, Kevin
    Slattum, Patricia
    INNOVATION IN AGING, 2022, 6 : 193 - 193
  • [5] An FDA quality assessment tool for evaluation of real-world evidence observational studies
    Bradley, Marie C.
    Hua, Wei
    Pinheiro, Simone
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 418 - 418
  • [6] Case-Control Studies Using "Real-world" Evidence to Assess Association
    Irony, Telba Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (10): : 1027 - 1028
  • [7] Real-world experiences with generating real-world evidence: Case Studies from PCORI's pragmatic clinical Studies program
    Neuman, Mark D.
    Kappelman, Michael D.
    Israel, Elliot
    Ellenberg, Susan S.
    Girman, Cindy
    Robb, Jess
    Rabinowitz, Allie
    Trontell, Anne
    CONTEMPORARY CLINICAL TRIALS, 2020, 98
  • [8] REALIZING TRANSPARENCY: REGISTRATION OF REAL-WORLD EVIDENCE STUDIES OF TREATMENT AND/OR COMPARATIVE EFFECTIVENESS
    Van Lier, H.
    Bell, J.
    Collins, F.
    VALUE IN HEALTH, 2018, 21 : S310 - S310
  • [9] The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness
    Cocoros, Noelle M.
    Arlett, Peter
    Dreyer, Nancy A.
    Ishiguro, Chieko
    Iyasu, Solomon
    Sturkenboom, Miriam
    Zhou, Wei
    Toh, Sengwee
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1189 - 1196
  • [10] Regulatory agencies disregard real-world effectiveness evidence on product labels beyond what is reasonable
    Dal-Re, Rafael
    Porcher, Raphael
    Rosendaal, Frits R.
    Schwarzer-Daum, Brigitte
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 153 : 83 - 90
12345